tiprankstipranks
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market
CSBR
Champions Oncology
RESEARCH TOOLSreports
Want to see CSBR full AI Analyst Report?

Champions Oncology (CSBR) Ratios

143 Followers

Champions Oncology Ratios

CSBR's free cash flow for Q1 2027 was $0.48. For the 2027 fiscal year, CSBR's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Apr 26Apr 25Apr 24Apr 23
Liquidity Ratios
Current Ratio
 1.03 0.96 0.94 0.63 0.90
Quick Ratio
 1.03 0.96 0.94 0.63 0.90
Cash Ratio
 0.23 0.24 0.41 0.12 0.47
Solvency Ratio
 0.02 <0.01 0.22 -0.19 -0.07
Operating Cash Flow Ratio
 -0.30 -0.22 0.31 -0.28 0.18
Short-Term Operating Cash Flow Coverage
 -8.76 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -9.54M$ -3.70M$ -6.20M$ -14.40M$ -10.22M
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.17 0.19 0.28 0.25
Debt-to-Equity Ratio
 2.54 1.15 1.62 -3.90 1.85
Debt-to-Capital Ratio
 0.72 0.53 0.62 1.34 0.65
Long-Term Debt-to-Capital Ratio
 0.72 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 8.55 6.85 8.57 -13.73 7.40
Debt Service Coverage Ratio
 -0.17 0.00 0.00 -192.18 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 -247.18 0.00
Debt to Market Cap
 0.15 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.71 0.33 0.45 0.55 0.64
Net Debt to EBITDA
 41.56 -0.80 -0.59 -0.89 0.73
Profitability Margins
Gross Profit Margin
49.30%48.00%50.15%41.38%45.18%
EBIT Margin
-1.46%-1.56%8.12%-14.52%-9.78%
EBITDA Margin
0.22%0.75%11.00%-10.79%-3.84%
Operating Profit Margin
-1.72%-1.92%8.51%-13.80%-8.26%
Pretax Profit Margin
-1.47%-1.56%8.12%-14.57%-9.78%
Net Profit Margin
-1.87%-1.98%8.26%-14.51%-9.90%
Continuous Operations Profit Margin
-1.87%-1.98%8.26%-14.51%-9.90%
Net Income Per EBT
127.24%126.48%101.62%99.56%101.29%
EBT Per EBIT
85.60%81.49%95.46%105.59%118.39%
Return on Assets (ROA)
-3.41%-4.35%14.53%-27.84%-15.55%
Return on Equity (ROE)
-27.88%-29.83%124.63%382.34%-115.08%
Return on Capital Employed (ROCE)
-7.16%-16.13%57.07%-150.75%-35.37%
Return on Invested Capital (ROIC)
-6.86%-13.28%48.64%-116.24%-32.27%
Return on Tangible Assets
-3.44%-4.41%14.69%-28.20%-15.70%
Earnings Yield
-1.60%-1.43%4.81%-11.07%-8.11%
Efficiency Ratios
Receivables Turnover
 4.46 4.51 5.07 5.27 6.72
Payables Turnover
 3.66 4.48 6.68 5.07 5.54
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 4.30 8.23 6.02 4.19 3.71
Asset Turnover
 1.82 2.20 1.76 1.92 1.57
Working Capital Turnover Ratio
 -866.60 -54.34 -12.13 -9.86 -1.18K
Cash Conversion Cycle
 -17.78 -0.60 17.39 -2.68 -11.65
Days of Sales Outstanding
 81.84 80.94 72.01 69.32 54.28
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 99.62 81.54 54.62 72.00 65.93
Operating Cycle
 81.84 80.94 72.01 69.32 54.28
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.40 -0.32 0.54 -0.45 0.29
Free Cash Flow Per Share
 -0.44 -0.36 0.51 -0.51 0.08
CapEx Per Share
 0.04 0.04 0.03 0.06 0.21
Free Cash Flow to Operating Cash Flow
 1.10 1.13 0.95 1.14 0.27
Dividend Paid and CapEx Coverage Ratio
 -9.71 -7.93 18.99 -7.34 1.38
Capital Expenditure Coverage Ratio
 -9.71 -7.93 18.99 -7.34 1.38
Operating Cash Flow Coverage Ratio
 -0.56 -0.99 1.21 -0.83 0.46
Operating Cash Flow to Sales Ratio
 -0.09 -0.08 0.13 -0.12 0.07
Free Cash Flow Yield
-8.66%-6.11%7.16%-10.61%1.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -64.56 -74.50 21.03 -9.03 -12.34
Price-to-Sales (P/S) Ratio
 1.17 1.39 1.72 1.31 1.22
Price-to-Book (P/B) Ratio
 18.21 20.93 25.89 -34.53 14.20
Price-to-Free Cash Flow (P/FCF) Ratio
 -11.55 -16.37 13.96 -9.42 60.77
Price-to-Operating Cash Flow Ratio
 -12.74 -18.43 13.22 -10.71 16.64
Price-to-Earnings Growth (PEG) Ratio
 0.31 0.60 -0.13 -0.23 0.01
Price-to-Fair Value
 18.21 20.93 25.89 -34.53 14.20
Enterprise Value Multiple
 574.32 183.22 15.00 -13.03 -31.07
Enterprise Value
 76.39M 82.08M 93.99M 70.52M 64.29M
EV to EBITDA
 574.32 183.22 15.00 -13.03 -31.07
EV to Sales
 1.26 1.38 1.65 1.41 1.19
EV to Free Cash Flow
 -12.45 -16.30 13.43 -10.11 59.37
EV to Operating Cash Flow
 -13.73 -18.35 12.73 -11.49 16.26
Tangible Book Value Per Share
 0.30 0.27 0.25 -0.17 0.32
Shareholders’ Equity Per Share
 0.28 0.28 0.28 -0.14 0.34
Tax and Other Ratios
Effective Tax Rate
 -0.27 -0.26 -0.02 <0.01 -0.01
Revenue Per Share
 4.36 4.30 4.17 3.70 3.98
Net Income Per Share
 -0.08 -0.08 0.34 -0.54 -0.39
Tax Burden
 1.27 1.26 1.02 1.00 1.01
Interest Burden
 1.01 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.15 0.15 0.12 0.19 0.21
SG&A to Revenue
 0.36 0.34 0.30 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.02 0.01 0.02 0.02
Income Quality
 4.90 3.81 1.57 0.84 -0.74
Currency in USD